Eric Forman

Eric Forman (board member) discloses dealings in Lixte Biotechnology Holdings, Inc. to SEC (Form 4). Between 4 February 2016 and 9 December 2022, the trades on record add up to 17 filings.

On the market, this insider has only ever bought: 12 purchases, €38k in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 1 share grant and 1 option exercise. 2022 to date brings 9 purchases and no sales.

The median purchase comes to €2,610. Of 12 purchases, 9 formed part of a group of insiders buying within 30 days of each other. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

The record was last updated on 13 December 2022 with an open-market purchase (€2,969) in Lixte Biotechnology Holdings, Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.